Suchergebnisse - "Leif Bostad"

PubPharm (7)

1

Utilizing the MEST score for prognostic staging in IgA nephropathy

in: BMC Nephrology | 2022

von Yngvar Lunde Haaskjold | Rune Bjørneklett | Leif Bostad | +3

2

A multiomics disease progression signature of low-risk ccRCC

in: Scientific Reports | 2022

von Philipp Strauss | Mariell Rivedal | Andreas Scherer | +9

3

AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease

in: Cancer Cell International | 2021

von Sigrid Nakken | Øystein Eikrem | Hans-Peter Marti | +8

4

Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study

in: BioMed Research International | 2018

von Rune Bjørneklett | Leif Bostad | Anne-Siri Fismen

5

Impact of Proteinase 3 versus Myeloperoxidase Positivity on Risk of End-Stage Renal Disease in ANCA-Associated Glomerulonephritis Stratified by Histological Classification: A Population-Based Cohort Study

in: Disease Markers | 2018

von Vilde Solbakken | Anne-Siri Fismen | Leif Bostad | +1

6

Cancer in ANCA-Associated Glomerulonephritis: A Registry-Based Cohort Study

in: International Journal of Nephrology | 2017

von Sanjeevan Sriskandarajah | Leif Bostad | Tor Åge Myklebust | +3

7

Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

in: BMC Urology | 2017

von Martin Pilskog | Christian Beisland | Lars A. Akslen | +5

1
[1]